160 related articles for article (PubMed ID: 37871653)
21. Gynecologic Manifestations of the DICER1 Syndrome.
Stewart CJ; Charles A; Foulkes WD
Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
[TBL] [Abstract][Full Text] [Related]
22. Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of
Golmard L; Vasta LM; Duflos V; Corsini C; Dubois d'Enghien C; McMaster ML; Harney LA; Carr AG; Ling A; Dijoud F; Gauthier A; Miettinen M; Cost NG; Gauthier-Villars M; Orbach D; Irtan S; Haouy S; Schultz KA; Stoppa-Lyonnet D; Coupier I; Stewart DR; Sirvent N
J Med Genet; 2022 Apr; 59(4):346-350. PubMed ID: 33782093
[No Abstract] [Full Text] [Related]
23. Novel insights into the mixed germ cell-sex cord stromal tumor of the testis: detection of chromosomal aneuploidy and further morphological evidence supporting the neoplastic nature of the germ cell component.
Michalova K; McKenney JK; Kristiansen G; Steiner P; Grossmann P; Putzova M; Martinek P; Chottova-Dvorakova M; Michal M; Hes O; Michal M
Virchows Arch; 2020 Nov; 477(5):615-623. PubMed ID: 32447491
[TBL] [Abstract][Full Text] [Related]
24. DICER1 hot-spot mutations in ovarian gynandroblastoma.
Wang Y; Karnezis AN; Magrill J; Tessier-Cloutier B; Lum A; Senz J; Gilks CB; McCluggage WG; Huntsman DG; Kommoss F
Histopathology; 2018 Aug; 73(2):306-313. PubMed ID: 29660837
[TBL] [Abstract][Full Text] [Related]
25. Review on Sertoli-Leydig Cell Tumours of the Ovary.
Muscat C; Calleja-Agius J
Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
[TBL] [Abstract][Full Text] [Related]
26. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
[TBL] [Abstract][Full Text] [Related]
27. Case report: an identical twin with Sertoli-Leydig cell tumor.
Cho K; Havelock JC; Gilks B; Dunne C
Gynecol Endocrinol; 2018 Jul; 34(7):563-566. PubMed ID: 29366348
[TBL] [Abstract][Full Text] [Related]
28. Update on Ovarian Sex Cord-Stromal Tumors.
Ordulu Z
Clin Lab Med; 2023 Jun; 43(2):245-274. PubMed ID: 37169445
[TBL] [Abstract][Full Text] [Related]
29. Update on Ovarian Sex Cord-Stromal Tumors.
Ordulu Z
Surg Pathol Clin; 2022 Jun; 15(2):235-258. PubMed ID: 35715160
[TBL] [Abstract][Full Text] [Related]
30. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
Young RH
Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
[TBL] [Abstract][Full Text] [Related]
31. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.
Rio Frio T; Bahubeshi A; Kanellopoulou C; Hamel N; Niedziela M; Sabbaghian N; Pouchet C; Gilbert L; O'Brien PK; Serfas K; Broderick P; Houlston RS; Lesueur F; Bonora E; Muljo S; Schimke RN; Bouron-Dal Soglio D; Arseneau J; Schultz KA; Priest JR; Nguyen VH; Harach HR; Livingston DM; Foulkes WD; Tischkowitz M
JAMA; 2011 Jan; 305(1):68-77. PubMed ID: 21205968
[TBL] [Abstract][Full Text] [Related]
32. Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.
Garcia A; Desrosiers L; Scollon S; Gruner S; Reuther J; Gandhi I; Patil N; Fuller MY; Dai H; Muzny D; Gibbs RA; Bercaw-Pratt JL; Rao SL; Rainusso N; Fisher KE; Lin FY; Plon SE; Parsons DW; Roy A
Cancer Genet; 2022 Apr; 262-263():53-56. PubMed ID: 35026696
[No Abstract] [Full Text] [Related]
33. A family with Sertoli-Leydig cell tumour, multinodular goiter, and
Haley M; Bindal P; McAuliffe A; Vredenburgh J
Curr Oncol; 2019 Jun; 26(3):183-185. PubMed ID: 31285663
[TBL] [Abstract][Full Text] [Related]
34. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
[TBL] [Abstract][Full Text] [Related]
35. [Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors].
Zheng XZ; Ma JH; Chen TB; Xu F; Zou ZY; Zhang LH; Jin YL; Zhan Y
Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):794-799. PubMed ID: 32746545
[No Abstract] [Full Text] [Related]
36. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
[TBL] [Abstract][Full Text] [Related]
37. Moderately differentiated Sertoli-Leydig cell tumour: a hormone-secreting neoplasm associated with DICER1 syndrome.
Khan S; Hodgson A
Int J Gynecol Cancer; 2023 Dec; 33(12):1981-1982. PubMed ID: 37543372
[No Abstract] [Full Text] [Related]
38. Nuclear Localization of β-Catenin in Sertoli Cell Tumors and Other Sex Cord-Stromal Tumors of the Testis: An Immunohistochemical Study of 87 Cases.
Zhang C; Ulbright TM
Am J Surg Pathol; 2015 Oct; 39(10):1390-4. PubMed ID: 26034868
[TBL] [Abstract][Full Text] [Related]
39. Ovarian tumors related to intronic mutations in DICER1: a report from the international ovarian and testicular stromal tumor registry.
Schultz KA; Harris A; Messinger Y; Sencer S; Baldinger S; Dehner LP; Hill DA
Fam Cancer; 2016 Jan; 15(1):105-10. PubMed ID: 26289771
[TBL] [Abstract][Full Text] [Related]
40. Mesenteric extraovarian Sertoli-Leydig cell tumor without DICER1 hotspot mutation: a case report.
Osakabe M; Sato C; Suzuki M; Sugimoto R; Fujita Y; Uesugi N; Ishida K; Itamochi H; Baba T; Sugai T
Diagn Pathol; 2019 Apr; 14(1):27. PubMed ID: 30935425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
